Directed vascular morphogenesis
Making endothelial cells build a hierarchical, leak-free blood-vessel tree from artery down to capillary wherever an engineered tissue needs one.
State of the art
Sacrificial-ink printing and self-assembling microvascular networks sustain perfused tissue constructs for weeks in vitro; ARPA-H PRINT (2024-2026) names capillary-scale vasculature as the central unmet challenge.
- Printing resolution stops at tens of microns while capillaries are 5-10 microns, so the smallest and most numerous vessels must self-assemble
- Engineered endothelium is thrombogenic, so perfused constructs clot
- No method guides anastomosis of a construct's vasculature to host vessels at scale
Who’s working on it
- Christopher ChenResearcherBoston University and Wyss Institute
Co-leads the Wyss 3D Organ Engineering Initiative and built vascular-engraftment-on-chip models of how engineered vessels connect to host tissue; elected to the National Academy of Medicine in 2025
- Jennifer LewisResearcherHarvard John A. Paulson School of Engineering and Applied Sciences
Developed SWIFT and co-SWIFT sacrificial-ink printing, which write perfusable and cell-lined channels through dense cellular matrices
- ARPA-H PRINT ↗Program
Up to 176.8 million dollars over five years across five teams, with capillary-scale vasculature named as the central unmet challenge
- Wyss Institute 3D Organ Engineering InitiativeAcademic lab
Where the printing and the endothelial biology are combined; its ReConstruct adipose programme is the nearest clinical translation of printed vasculature
- Antonios MikosResearcherRice University
Part of the Wake Forest-led PRINT kidney team announced in 2026, supplying the biomaterials side of printing perfusable renal tissue
- PrintBioStartup
Industry partner in the federal kidney bioprinting programme, one of very few companies working on vascularised print fidelity rather than cell therapy
What to invest in
| Kind | Investment | Scale |
|---|---|---|
| research | Morphogen and flow-cue programs that drive capillary self-assembly into printed scaffolds, with perfusion and permeability metrics | $$ $10M – $100M |
| research | Non-thrombogenic engineered endothelium validated under physiologic flow for months | $$ $10M – $100M |
Depends on
A root node: no prerequisites modeled.